About Us:
Longdom Conferences is elated to unveil The International Congress on Virology, Emerging Diseases, and Vaccines scheduled for August 29-30, 2024, in the vibrant city of Toronto, Canada anchored in the theme of “Viruses Unveiled: Tackling Tomorrow's Threats with Vaccines Today”. This virology conference aims to bring together educators, emerging scholars, and curious minds to foster innovation and collaboration. “Here, they can both spotlight and dissect the latest frontiers, prospects, and intricacies entrenched within the domains of Virology, Emerging Diseases & Vaccines.
Lead the way in innovation by securing your Registration and submitting your abstract to this momentous virology conference, as the official countdown has started!
Sessions & Tracks
Track 1:Viral Pathogenesis and Host-Pathogen Interactions:
Molecular mechanisms of viral entry, replication, and dissemination. Immune responses to viral infections. Evolutionary aspects of host pathogen interactions.
Track 2:Emerging and Re-emerging Viral Diseases:
Surveillance and identification of new viral threats. Case studies on recent outbreaks and their management.
Track 3:Strategies for rapid response and containment.
Vaccines: Development and Innovation: Advancements in vaccine design and formulation. Novel technologies in vaccine development (mRNA, viral vectors, etc.). Challenges and breakthroughs in vaccine production and distribution.
Track 4:Antiviral Therapeutics:
Development of antiviral drugs and therapies. Drug resistance and strategies to overcome it. Clinical trials and outcomes of antiviral interventions.
Track: Diagnostic Techniques in Virology:
Molecular and serological diagnostic methods. Point-of-care diagnostics for viral infections. Advances in diagnostic technologies.
Track 5:Epidemiology and Public Health:
Global trends in viral infections and disease burden. Public health strategies for viral disease prevention and control. Socio-economic impacts of viral outbreaks.
Track 6:Immunization Programs and Strategies: Vaccination policies and implementation. Immunization coverage and challenges.
Community engagement and education for vaccine acceptance.
Track 7:One Health Approaches to Viral Diseases: Understanding the interface between human, animal, and environmental health. Zoonotic transmission and surveillance. Collaborative efforts in preventing cross-species transmission.
Track 8:Biosecurity and Bioterrorism Preparedness:
Measures to prevent accidental release of dangerous pathogens. Strategies for responding to intentional biological threats.
International cooperation in biosecurity.
Track 9:Ethical, Legal, and Social Implications of Virology Research:
Ethical considerations in clinical trials and research. Legal frameworks for handling infectious diseases. Social aspects of vaccination and public health policies.
Why to Attend/ Sponsor/ Exhibitor
The International Conference on Virology, Emerging Diseases, and Vaccines is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products of your company, the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent research on Virology Applications.
Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, Email, Digital, and increasingly social and business networking websites.
Your sponsorship/exhibition will give your organization fantastic exposure to around 150 attendees and offer a unique opportunity to align your brand with this very highly successful, high-profile event.
Virology 2024 will provide a terrific and diverse platform to interact and network with fellow industry colleagues.
Benefits of Attending
Targeted Audience: